UTHR Q3'26 Earnings: revenue estimate is 781.14M USD

What happened

United Therapeutics Corporation (UTHR) will report its Q3'26 results on November 04 before the market opens at 6:30 AM ET. The revenue estimate is 781.14 million USD and the earnings per share estimate is 6.01 USD.

Confirmed

Global impact / market context

Investors use revenue and earnings per share estimates, which show expected sales and profit per share, to judge whether results beat or miss expectations. Past quarters show reported revenue and EPS repeatedly fell short of estimates, so another shortfall could pressure the stock.

Analyst inference

The article shows UTHR missed revenue estimates in each of the last four quarters, and EPS missed in two of those quarters. This pattern suggests expectations may already be cautious ahead of the November 04 report.

Analyst inference

What to watch

1. Watch whether reported Q3'26 revenue and EPS come in above or below the 781.14 million USD revenue estimate and the 6.01 USD EPS estimate on November 04. Confirmed
2. Compare the new results with the prior quarters shown in the article to see whether the recent pattern of revenue and EPS estimates continues into the Q3'26 report. Proposed
3. If revenue or EPS again falls short of estimates, investors may lower their expectations for future sales and profit, which could weigh on the stock price after the release. Analyst inference

Evidence

• Original source link unavailable